Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2352 Neoplasms 1707 Prostatic Neoplasms 1197 Lung Neoplasms 923 Colorectal Neoplasms 882 Carcinoma, Non-Small-Cell Lung 867 Leukemia, Myeloid, Acute 593 Pancreatic Neoplasms 577 Multiple Myeloma 549 Carcinoma, Hepatocellular 516 Brain Neoplasms 513 Neoplasm Metastasis 459 Head and Neck Neoplasms 454 Melanoma 414 Ovarian Neoplasms 413 Glioblastoma 402 Precursor Cell Lymphoblastic Leukemia-Lymphoma 400 Stomach Neoplasms 375 Uterine Cervical Neoplasms 365 Squamous Cell Carcinoma of Head and Neck 361 Rectal Neoplasms 341 Recurrence 336 Sarcoma 325 Hematologic Neoplasms 323 Colonic Neoplasms 323 Lymphoma 319 Triple Negative Breast Neoplasms 291 Carcinoma, Renal Cell 283 Urinary Bladder Neoplasms 281 Glioma 278

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ER+HER2- Breast Cancer × 1 year × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡